Cuba to multiply production of monoclonal antibodies

HAVANA TIMES, Sept. 20 – Cuba hopes to multiply by 10 the production of monoclonal antibodies against cancer after the conclusion of the adjustment process and start up of the new plant of the Molecular Immunology Centre (CIM), located in the scientific hub west of the island’s capital, David Curbelo Rodríguez, director of the installation, announced. According to the specialist, one of the fundamental aims is to meet the demand for Nimotuzumab, which reduces advanced tumours of the brain, head and esophagus, reported IPS.